Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.41 |
| ▸ | FDPS | P14324 | 9/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28897317 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL15068127 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL6049085 | 1.00 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL2723204 | 0.97 | — | — | |
| SCHEMBL8037927 | 0.88 | — | — | |
| SCHEMBL31297408 | 0.87 | FFAR1 (0.33) | — | |
| SCHEMBL31297413 | 0.87 | FFAR1 (0.33) | — | |
| SCHEMBL31297410 | 0.87 | FFAR1 (0.33) | — | |
| SCHEMBL31297412 | 0.87 | FFAR1 (0.33) | — | |
| Naphthalene SCHEMBL20979868 | 0.82 | HTT (0.43) | THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170283368-A1 | METHODS FOR SYNTHESIZING SUBSTITUTED TETRACYCLINE COMPOUNDS | PARATEK PHARMACEUTICALS, INC. | 2017-10-05 | — | — | US | claimed |
| EP-2014797-A2 | Coating composition for interconnection part of electrode and plasma display panel including the same | Samsung SDI Co., Ltd. (KR) | 2009-01-14 | — | — | EP | claimed |
| US-20080303439-A1 | Coating composition for interconnection part of electrode and plasma display panel including the same | SAMSUNG SDI CO., LTD., A CORP. OF THE REPUBLIC OF KOREA (KR) | 2008-12-11 | — | — | US | claimed |
| EP-0706653-B1 | SYSTEM FOR BENZODIAZEPINE DETECTION | BIO RAD LABORATORIES (US) | 1998-03-04 | — | — | EP | claimed |
| EP-0706653-A1 | SYSTEM FOR BENZODIAZEPINE DETECTION | BIO-RAD LABORATORIES, INC. (US) | 1996-04-17 | — | — | EP | claimed |
| US-5416023-A | System for benzodiazepine detection | BIO-RAD LABORATORIES, INC. (US) | 1995-05-16 | — | — | US | claimed |
| WO-1995001566-A1 | SYSTEM FOR BENZODIAZEPINE DETECTION | BIO-RAD LABORATORIES, INC. (US) | 1995-01-12 | — | — | WO | claimed |
| US-5352585-A | System for benzodiazepine detection | BIO-RAD LABORATORIES, INC. (US) | 1994-10-04 | — | — | US | claimed |
| US-20250340507-A1 | METHODS FOR SYNTHESIZING SUBSTITUTED TETRACYCLINE COMPOUNDS | PARATEK PHARM INNC (US) | 2025-11-06 | — | — | US | disclosed |
| US-12422446-B2 | Pretreatment method of an automatic analyzer | HITACHI HIGH-TECH CORPORATION (JP) | 2025-09-23 | — | — | US | disclosed |
| EP-3968029-B1 | AUTOMATIC ANALYSIS DEVICE PRETREATMENT METHOD | HITACHI HIGH TECH CORP (JP) | 2025-05-21 | — | — | EP | disclosed |
| CN-113785204-B | Pretreatment method for automatic analysis device | 株式会社日立高新技术 | 2024-10-15 | — | — | CN | disclosed |
| US-12037357-B2 | Compounds for activating invariant natural killer T-cells and methods of use in eliminating inflammatory senescent cells | DECIDUOUS THERAPEUTICS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| US-20240025936-A1 | COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS | DECIDUOUS THERAPEUTICS, INC. (US) | 2024-01-25 | — | — | US | disclosed |
| US-5427915-A | Using a crystalline anisotropic polymerized polyunsaturated lipid monolayer capable of specific binding to analyte | BIOCIRCUITS CORPORATION (US) | 1995-06-27 | — | — | US | disclosed |
| WO-1995001566-A1 | SYSTEM FOR BENZODIAZEPINE DETECTION | BIO-RAD LABORATORIES, INC. (US) | 1995-01-12 | — | — | WO | disclosed |
| EP-0629443-A1 | Process for preparing a metal catalyst with in situ generated carrier for the hydrogenation of organic compounds and catalyst obtained by means of such a process | MINISTERO DELL' UNIVERSITA' E DELLA RICERCA SCIENTIFICA E TECNOLOGICA (IT) | 1994-12-21 | — | — | EP | disclosed |
| US-5268305-A | Multi-optical detection system | BIOCIRCUITS CORPORATION (US) | 1993-12-07 | — | — | US | disclosed |
| EP-0563317-A1 | MULTI-OPTICAL DETECTION SYSTEM | BIOCIRCUITS CORPORATION (US) | 1993-10-06 | — | — | EP | disclosed |
| WO-1992010758-A1 | MULTI-OPTICAL DETECTION SYSTEM | BIOCIRCUITS CORPORATION (US) | 1992-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12037357-B2 | Compounds for activating invariant natural killer T-cells and methods of use in eliminating inflammatory senescent cells | IL2, IL4, PBK | TSHR 3328/4885THRB 2737/4885GGPS1 1471/4885 |
| US-20240025936-A1 | COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS | IL2, PBK, IL4 | TSHR 3553/4885THRB 3093/4885GGPS1 1741/4885 |
| US-20250340507-A1 | METHODS FOR SYNTHESIZING SUBSTITUTED TETRACYCLINE COMPOUNDS | TET3, TET1, DHFR | TSHR 2369/4885THRB 1828/4885GGPS1 87/4885 |
| US-20170283368-A1 | METHODS FOR SYNTHESIZING SUBSTITUTED TETRACYCLINE COMPOUNDS | TET3, TET1, DHFR | TSHR 2369/4885THRB 1828/4885GGPS1 87/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.